Allergy News and Research

RSS

The term allergy encompasses a wide range of conditions; it is not a disease in itself. In 1906 Clemens von Pirquet was the first to describe allergies as a changed or altered reaction of the immune system in response to exposure to foreign proteins. These days the term allergy – medically termed hypersensitivity, signifies an exaggerated reaction to foreign substances.

ATCC announces new award from BARDA to provide centralized storage and bioprocessing services for Project NextGen

ATCC, the world’s premier biological materials management and standards organization, today announced a five-year, $87 million award from the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response within the U.S. Department of Health and Human Services, to support the development of next-generation medical countermeasures (MCMs) to protect Americans from public health security threats such as coronaviruses.

From ATCC 5 Jan 2024

Previously unrecognized class of antibodies can broadly neutralize multiple virus strains

Researchers have identified a previously unrecognized class of antibodies-;immune system proteins that protect against disease-;that appear capable of neutralizing multiple forms of flu virus.

21 Dec 2023

Unraveling nuanced roles of JAK inhibitors in inflammation

Researchers at the Icahn School of Medicine at Mount Sinai have gained a deeper understanding of the nuanced roles of JAK inhibitors, or modulators, in inflammation across various cell types and tissues.

21 Dec 2023

Two new practice parameters offer recommendations for treating anaphylaxis and atopic dermatitis

Two new practice parameters from the Joint Task Force for Practice Parameters (JTFPP) offer evidence-based recommendations for the diagnosis and management of anaphylaxis and atopic dermatitis (AD) in pediatric and adult patients.

18 Dec 2023

NIAID study identifies critical T-cell function missing in prior HIV vaccine candidates

An effective HIV vaccine may need to prompt strong responses from immune cells called CD8+ T cells to protect people from acquiring HIV, according to a new study from researchers at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, and colleagues.

14 Dec 2023

Advancements in food allergy research promise improved diagnosis and treatment options

A review in the Journal of Allergy and Clinical Immunology discusses the global trends in food allergy prevalence, with stabilization in developed regions and an increase in developing countries, alongside advancements in understanding the mechanisms, diagnosis, and treatment of food allergies.

13 Dec 2023

Climate change and the future of allergic disease management

As we head into the new year, some issues may be coming into sharper focus for those involved in allergy-immunology issues.

13 Dec 2023

T cells can recognize and fight the "Pirola" variant, new study suggests

In August, researchers detected a new SARS-CoV-2 "variant of concern" in patients in Israel and Denmark.

8 Dec 2023

Early treatment offers chance at medication-free remission for pediatric HIV patients

An unexpectedly high percentage of children, who were born with HIV and started treatment within 48 hours of life, exhibit biomarkers by 2 years of age that may make them eligible to test for medication-free remission, according to a multinational study published in Lancet HIV.

7 Dec 2023

PFAS exposure linked to weaker bones in young people

Per- and polyfluoroalkyl substances (PFAS), manufactured chemicals used in products such as food packaging and cosmetics, can lead to reproductive problems, increased cancer risk and other health issues.

6 Dec 2023

Blocking an allergy pathway unleashes antitumor immunity in mouse models of non-small cell lung cancer

Researchers at the Icahn School of Medicine at Mount Sinai have identified an allergy pathway that, when blocked, unleashes antitumor immunity in mouse models of non-small cell lung cancer (NSCLC).

6 Dec 2023

Research uncovers stealthy strategy of SARS-CoV-2 infection

Researchers have discovered a novel mechanism whereby the SARS-CoV-2 virus, which causes COVID-19, can vary its mode of infection in human cells. Published in the journal eLife, a team from the University of Minnesota and the Midwest Antiviral Drug Discovery (AViDD) Center found the virus can alternate between being highly infectious and avoiding detection by the immune system.

5 Dec 2023

Breakthrough research identifies new ways to target skin autoimmune diseases

Breakthrough research has revealed new ways to remove immune cells that cause skin autoimmune diseases without affecting protective cells that fight infection and cancer.

30 Nov 2023

Scientists uncover the mystery behind painless leishmaniasis lesions

For the first time, scientists have begun to figure out why the disfiguring skin lesions caused by cutaneous leishmaniasis don't hurt.

30 Nov 2023

BU researcher wins NIH award to quantify long-term impact of nutritional interventions on TB incidence

Pranay Sinha, MD, assistant professor of medicine at Boston University Chobanian & Avedisian School of Medicine, has received a National Institutes of Health Mentored Research Scientist Development Award (K01).

30 Nov 2023

Study identifies common skin bacterium as previously unknown culprit behind itch

Scientists at Harvard Medical School have shown for the first time that a common skin bacterium -; Staphylococcus aureus -; can cause itch by acting directly on nerve cells.

22 Nov 2023

Study finds among outpatients with mild to moderate COVID-19, treatment with fluvoxamine does not reduce duration of symptoms

Researchers investigate the effects of high-dose fluvoxamine among patients with mild-to-moderate COVID-19.

22 Nov 2023

Allergy News and Research

Further Reading

ATCC announces new award from BARDA to provide centralized storage and bioprocessing services for Project NextGen

Previously unrecognized class of antibodies can broadly neutralize multiple virus strains

Unraveling nuanced roles of JAK inhibitors in inflammation

Two new practice parameters offer recommendations for treating anaphylaxis and atopic dermatitis

NIAID study identifies critical T-cell function missing in prior HIV vaccine candidates

Advancements in food allergy research promise improved diagnosis and treatment options

Climate change and the future of allergic disease management

T cells can recognize and fight the "Pirola" variant, new study suggests

Early treatment offers chance at medication-free remission for pediatric HIV patients

PFAS exposure linked to weaker bones in young people

Blocking an allergy pathway unleashes antitumor immunity in mouse models of non-small cell lung cancer

Research uncovers stealthy strategy of SARS-CoV-2 infection

Breakthrough research identifies new ways to target skin autoimmune diseases

Scientists uncover the mystery behind painless leishmaniasis lesions

BU researcher wins NIH award to quantify long-term impact of nutritional interventions on TB incidence

Study identifies common skin bacterium as previously unknown culprit behind itch

Study finds among outpatients with mild to moderate COVID-19, treatment with fluvoxamine does not reduce duration of symptoms

Autoimmune rheumatic disease patients benefit significantly from fourth COVID-19 vaccine dose

COVID-19 pandemic slowed progress toward ending HIV epidemic in the U.S.

Study reveals underuse of antiviral medications in young children with influenza

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News